Minimum recognition unit of a pem mucin tandem repeat specific monoclonal antibody

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 5833943
SERIAL NO

08764938

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The peptide EPPT (Glu-Pro-Pro-Thr) (SEQ ID NO:1) selectively binds a mucin expressed by epithelial tumors. It may be incorporated into larger molecules, such as peptides consisting of the sequence EPPT and further amino acids to form a peptide, and may be radiolabelled or used to guide toxins, etc. to cells expressing the mucin.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CANCER THERAPEUTICS LIMITEDHANGER LANE WEST AFRICA HOUSE EALING LONDON W5 3Q

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Courtenay-Luck, Nigel Stephen London, GB 3 4

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation